These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9838672)

  • 1. Cellular immune reaction in hyperacute rejection.
    Wada S; Ochikubo H; Sugawara Y; Sueda T; Fujii K; Kajihara H; Matsuura Y
    Transplant Proc; 1998 Nov; 30(7):3818-20. PubMed ID: 9838672
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative immunopathologic study of hyperacute rejection in naive and sensitized rodent cardiac xenograft models.
    Wu GD; Cramer DV; Chapman FA; Wang HK; Chien K; Cole J; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):464-5. PubMed ID: 8438380
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute liver failure attenuates hyperacute xenograft rejection.
    Stockmann HB; Hiemstra CA; Meijer R; Marquet RL; IJzermans JN
    Transplant Proc; 2000 Aug; 32(5):1114-5. PubMed ID: 10936386
    [No Abstract]   [Full Text] [Related]  

  • 4. Phylogenetic disparity does not always equate with hyperacute rejection in xenotransplantation.
    Braidley PC; Dunning JJ; Wallwork J; White DJ
    Transplant Proc; 1994 Jun; 26(3):1230-1. PubMed ID: 8029897
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of perfluorotributylamine/pluronic F-68 stem-emulsion (FC43se) against hyperacute rejection in discordant lung xenografts.
    Sugawara Y; Matsuura Y; Sueda T; Wada S; Ochikubo H; Kajihara H
    Transplant Proc; 1998 Nov; 30(7):3826-30. PubMed ID: 9838675
    [No Abstract]   [Full Text] [Related]  

  • 6. Normal human polyclonal immunoglobulins for intravenous use significantly delay hyperacute xenograft rejection.
    Latremouille C; Haeffner-Cavaillon N; Goussef N; Mandet C; Hinglais N; Bruneval P; Bariety J; Carpentier A; Glotz D
    Transplant Proc; 1994 Jun; 26(3):1285. PubMed ID: 8029910
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of perfluorochemical-based artificial blood compounds in discordant xenotransplantation.
    Wada S; Kajihara H; Murakami H; Sueda T; Matsuura Y
    Artif Organs; 1996 Aug; 20(8):930-5. PubMed ID: 8853809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical effects of xenografting in the nude rat: effect of splenectomy on aberrant graft rejection.
    Araneda D; Carobbi A; Thomas J; Thomas F
    Transplant Proc; 1992 Apr; 24(2):495-6. PubMed ID: 1566402
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin.
    Magee JC; Collins BH; Harland RC; Bollinger RR; Frank MM; Platt JL
    Transplant Proc; 1995 Feb; 27(1):271. PubMed ID: 7878999
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of C3a and C5a in hyperacute rejection of guinea pig-to-rat cardiac xenografts.
    Pruitt SK; Baldwin WM; Sanfilippo F
    Transplant Proc; 1996 Apr; 28(2):596. PubMed ID: 8623292
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperacute xenograft rejection in the guinea pig to rat heart transplantation model.
    Bouwman E; Loonen EM; Wolvekamp M; de Bruin RW; Jeekel J; Marquet RL
    Transplant Proc; 1990 Jun; 22(3):1063-4. PubMed ID: 2349662
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed xenograft rejection in complement-depleted T-cell-deficient rat recipients of guinea pig cardiac grafts.
    Candinas D; Bach FH; Hancock WW
    Transplant Proc; 1996 Apr; 28(2):678. PubMed ID: 8623340
    [No Abstract]   [Full Text] [Related]  

  • 13. C1-Inh and heparan sulfate can prevent discordant rejection.
    Di Stefano R; Frosini F; Scavuzzo M; Ambrogi M; Fagiolini A; Ferrari M; Pelosi G; Mosca F
    Transplant Proc; 1994 Jun; 26(3):1172-3. PubMed ID: 8029876
    [No Abstract]   [Full Text] [Related]  

  • 14. Brequinar sodium and liver hemoperfusion in xenotransplantation.
    Chastanet S; Cursio R; Gugenheim J; Baldini E; Chevallier A; Damais A; Charpentier B; Mouiel J
    Transplant Proc; 1998 Aug; 30(5):2244-5. PubMed ID: 9723457
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural IgM play a major role in hyperacute rejection of discordant heart xenografts.
    Gambiez L; Salamé E; Chéreau C; Calmus Y; Ayani E; Houssin D; Weill B
    Transplant Proc; 1992 Apr; 24(2):441-2. PubMed ID: 1566380
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model.
    Leventhal JR; Matas AJ; Sun LH; Reif S; Bolman RM; Dalmasso AP; Platt JL
    Transplantation; 1993 Jul; 56(1):1-8. PubMed ID: 8333031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
    Chong AS; Shen J; Xiao F; Blinder L; Foster P; Sankary H; Williams JW
    Transplant Proc; 1996 Apr; 28(2):684. PubMed ID: 8623344
    [No Abstract]   [Full Text] [Related]  

  • 18. White blood cells and platelets are integral to the hyperacute rejection of the pig heart by human blood.
    Young VK; Kaspar-König W; Tew DN; Wallwork J; White DJ; Pierson RN
    Transplant Proc; 1995 Feb; 27(1):272-3. PubMed ID: 7879000
    [No Abstract]   [Full Text] [Related]  

  • 19. Donor pretreatment prolongs survival of discordant xenografts.
    Jefferson KP; Tyerman KS; McLeish M; Collier DS; Thiru S
    Transplant Proc; 1991 Aug; 23(4):2280-1. PubMed ID: 1871871
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of various routes of donor-specific antigen administration on graft survival in a model of discordant heart xenotransplantation.
    Akpinar E; Arikan U; Bilgin N
    Transplant Proc; 1998 May; 30(3):809-11. PubMed ID: 9595108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.